Turned multi-omics and clinical data into a preclinically validated strategy for cancer prevention or treatment by identifying key molecular drivers and therapeutic targets through rigorous biological and mathematical reasoning.

Developed organ-in-plate models to investigate the initial host-pathogen interaction in situ in human lungs, paving the way for early detection of asymptomatic infections.